Dr. J. Bernadette Moore
- Position: Associate Professor
- Areas of expertise: obesity; non-alcoholic fatty liver disease; hepatic nutrient metabolism; molecular nutrition; dietary sugars (glucose and fructose); proteomics; multi-scale modelling; systems biology
- Email: J.B.Moore@leeds.ac.uk
- Phone: +44(0)113 343 9900
- Location: 2.33 Chemistry Building (access through Parkinson)
- Website: LinkedIn | ORCID
After obtaining her Ph.D. in Nutritional Sciences at the University of Florida, Dr. Moore earned the prestigious Christine Mirzayan Science Policy fellowship to the National Academy of Sciences in Washington DC. Her interest in childhood obesity was fostered during this fellowship where she contributed to the landmark Institute of Medicine report ‘Preventing Childhood Obesity: Health in the Balance’. Subsequently, she completed an intramural post-doctoral fellowship at the National Institute of Diabetes, Digestive and Kidney Diseases (NIH); then earned a Marie Curie Transfer of Knowledge Fellowship that brought her back to her home country Ireland at the National University of Ireland, Maynooth in 2005. Prior to her appointment at the University of Leeds in 2016, Dr. Moore was Senior Lecturer in Molecular Nutrition at the University of Surrey, where she had been since 2007.
- Research Group Leader, Nutrition & Public Health
- Deputy Health & Safety Officer
Research in Dr. Moore’s group is focused on the role of hepatic nutrient metabolism in healthy ageing and non-alcoholic fatty liver disease (NAFLD). NAFLD is now the most common cause of liver disease affecting an estimated 30% of adults and 10% of children worldwide. There are currently no effective pharmaceutical therapies for NAFLD but nutrition is a key modifiable risk factor and weight loss underpins clinical management.
Applying a variety of genomic, proteomic, and systems biology tools alongside nutritional intervention studies, Dr. Moore's long-term vision is clinical and public health translation; ultimately addressing unmet needs for the discovery of diagnostic/prognostic biomarkers and the development of novel therapeutics. Current projects include: (i) utilizing quantitative proteomics to dissect the molecular etiology and pathogenesis of NAFLD; (ii) developing multi-scale mathematical models capable of predicting hepatic nutrient metabolism in silico; and (iii) clinical nutrition aspects related to dietary assessment and management of NAFLD in children and adults.
- BSc. Human Nutrition
- BSc. Chemical Sciences
- PhD. Nutritional Sciences
- PGC. Academic Practice
- The Nutrition Society
- Royal Society of Medicine
- Biochemical Society
Research groups and institutes
- Nutrition and Public Health
- Nutritional Epidemiology
- Obesity, Cancer and Metabolic Disease
- Human Nutrition and Lifestyle Intervention